<code id='039D12DD0B'></code><style id='039D12DD0B'></style>
    • <acronym id='039D12DD0B'></acronym>
      <center id='039D12DD0B'><center id='039D12DD0B'><tfoot id='039D12DD0B'></tfoot></center><abbr id='039D12DD0B'><dir id='039D12DD0B'><tfoot id='039D12DD0B'></tfoot><noframes id='039D12DD0B'>

    • <optgroup id='039D12DD0B'><strike id='039D12DD0B'><sup id='039D12DD0B'></sup></strike><code id='039D12DD0B'></code></optgroup>
        1. <b id='039D12DD0B'><label id='039D12DD0B'><select id='039D12DD0B'><dt id='039D12DD0B'><span id='039D12DD0B'></span></dt></select></label></b><u id='039D12DD0B'></u>
          <i id='039D12DD0B'><strike id='039D12DD0B'><tt id='039D12DD0B'><pre id='039D12DD0B'></pre></tt></strike></i>

          Home / Wikipedia / hotspot

          hotspot


          hotspot

          author:focus    Page View:19
          Alexis Borisy
          Venture capitalist Alexis Borisy Vanessa Leroy for STAT

          EQRx is done, sold for its cash.

          The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

          advertisement

          The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In